Sotatercept Active in Patients With Myeloproliferative Neoplasm–Associated Anemia

Downloadable slides from a Clinical Care Options (CCO) video on treatment strategies for patients with lower risk myelodysplastic syndrome (MDS)

Rami S. Komrokji, MD Released: January 15, 2021

Read expert answers to clinician questions on optimizing the care of patients with CLL in today’s practice, from Clinical Care Options (CCO)

Ian W. Flinn, MD, PhD Susan M. O'Brien, MD John Pagel, MD, PhD Released: January 15, 2021

Brief expert video from Clinical Care Options (CCO) on recommended treatment strategies for patients with lower-risk myelodysplastic syndrome (MDS)

Rami S. Komrokji, MD Physicians: maximum of 0.25 AMA PRA Category 1 Credits™ Registered Nurses: 0.25 Nursing contact hours Pharmacists: 0.25 contact hours (0.025 CEUs) Released: January 15, 2021 Expired: January 14, 2022

Expert answers to clinician questions on current challenges in managing patients with myelodysplastic syndromes (MDS), from Clinical Care Options (CCO)

Guillermo Garcia-Manero, MD Rami S. Komrokji, MD Jamile Shammo, MD, FASCP, FACP Released: January 11, 2021